It has been a mixed year for Fulcrum Therapeutics, Inc. insiders: $1.5 million bought by two people and $59.2 million sold by four, so more selling than buying overall.
TANG KEVIN (10% Owner) made the biggest buy, worth around $415,000.
155 investment managers listed FULC in their latest 13F filings (Q2 2026); more funds bought than sold. Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | TANG KEVIN | 10% Owner | Buy | 116,671 | $3.56 | $415K | SEC |
| Jul 20, 2026 | TANG KEVIN | 10% Owner | Buy | 50,945 | $3.52 | $179K | SEC |
| Jul 15, 2026 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 107,377 | $3.56 | $382K | SEC |
| Jul 15, 2026 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 75,952 | $3.58 | $272K | SEC |
| Jul 15, 2026 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 53,651 | $3.56 | $191K | SEC |
| Jul 15, 2026 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 12,966 | $3.54 | $46K | SEC |
| Jun 30, 2026 | Ezekowitz Alan | Director | Sell | 18,000 | $3.65 | $66K | SEC |
| Feb 4, 2026 | Gould Robert J | Director | Sell | 15,000 | $10.87 | $163K | SEC |
| Feb 4, 2026 | Gould Robert J | Director | Sell | 15,000 | $10.72 | $161K | SEC |
| Jan 6, 2026 | Gould Robert J | Director | Sell | 15,000 | $11.87 | $178K | SEC |
| Dec 17, 2025 | Oltmans Curtis Gale | Executive Officer | Sell | 3,452 | $12.92 | $45K | SEC |
| Dec 10, 2025 | RA Capital Healthcare Fund LP | 10% Owner | Sell | 1,377,020 | $13.33 | $18.4M | SEC |
| Dec 10, 2025 | RA Capital Healthcare Fund LP | 10% Owner | Sell | 91,722 | $14.98 | $1.4M | SEC |
| Dec 10, 2025 | RA Capital Healthcare Fund LP | 10% Owner | Sell | 2,706,397 | $14.28 | $38.6M | SEC |
| Nov 21, 2025 | Gould Robert J | Director | Sell | 15,000 | $11.03 | $165K | SEC |
In the last 12 months Fulcrum Therapeutics, Inc. insiders made open-market purchases worth about $1.5 million and sales worth about $59.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in FULC was filed on 2026-07-20.
155 investment managers reported holding FULC in SEC Form 13F filings for Q2 2026.
No congressional trades in FULC were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).